Table 4.
Prevalence of the most common high-risk HPV genotypes by cytological abnormalities.
|
Cervical cytological status N (Col %) |
||||||
|---|---|---|---|---|---|---|
| LGSIL | HGSIL | |||||
|
Hr-HPV (α) genotypes# |
Normal N = 51 |
Inflammatory/ Atypia N = 164 |
CIN 1 N = 27 |
CIN 2 N = 29 |
CIN 3 N = 29 |
Total N = 300 |
| HPV58 | 0 (0.0) | 16 (9.8) | 3 (11.1) | 7 (24.1) | 8 (27.6) | 34 (11.3) |
| HPV52 | 4 (7.8) | 14 (8.5) | 1 (3.7) | 8 (27.6) | 6 (20.7) | 33 (11.0) |
| HPV53 | 4 (7.8) | 19 (11.6) | 4 (14.8) | 2 (6.9) | 3 (10.3) | 32 (10.7) |
| HPV16 | 2 (3.9) | 8 (4.9) | 4 (14.8) | 2 (6.9) | 11 (37.9) | 27 (9.0) |
| HPV18 | 1 (2.0) | 7 (4.3) | 4 (14.8) | 2 (6.9) | 0 (0.0) | 14 (4.7) |
| HPV51 | 0 (0.0) | 7 (4.3) | 2 (7.4) | 4 (13.8) | 0 (0.0) | 13 (4.3) |
| All Hr-HPVs | 9 (17.7) | 69 (42.1) | 13 (48.2) | 25 (86.2) | 25 (86.2) | 141 (47.0) |
| HPV58 & others∧ | 2 (3.9) | 49 (29.9) | 5 (18.5) | 13 (44.8) | 11 (37.9) | 80 (26.7) |
| HPV52 & others∧ | 6 (11.8) | 47 (28.7) | 3 (11.1) | 15 (51.7) | 8 (27.6) | 79 (26.3) |
| HPV53 & others∧ | 6 (11.8) | 48 (29.3) | 5 (18.5) | 8 (27.6) | 6 (20.7) | 73 (24.3) |
| HPV16 & others∧ | 4 (7.8) | 40 (24.4) | 6 (22.2) | 9 (31.0) | 14 (48.3) | 73 (24.3) |
| HPV18 & others∧ | 3 (5.9) | 40 (24.4) | 6 (22.2) | 9 (31.0) | 4 (13.8) | 62 (20.7) |
| HPV51 & others∧ | 2 (3.9) | 41 (25.0) | 3 (11.1) | 11 (37.9) | 4 (13.8) | 61 (20.3) |
#
High-risk HPV genotypes: included high-risk genotypes (16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, and 59) and potential high-risk genotypes (53, 66, 67, 68, 70, 82).
∧
Others: included high-risk genotypes (31, 33, 35, 39, 45, and 59) and potential high-risk genotypes (66, 67, 68, 70, 82).